REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 85 filers reported holding REGULUS THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | -100.0% | 1,834 | +0.5% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 1,825 | -1.6% | 0.00% | – |
| Q1 2018 | $1,000 | -66.7% | 1,854 | -35.4% | 0.00% | – |
| Q4 2017 | $3,000 | -57.1% | 2,872 | -49.6% | 0.00% | – |
| Q3 2017 | $7,000 | -89.9% | 5,699 | -91.8% | 0.00% | – |
| Q2 2017 | $69,000 | -66.2% | 69,916 | -43.6% | 0.00% | – |
| Q1 2017 | $204,000 | -64.3% | 124,030 | -51.2% | 0.00% | – |
| Q4 2016 | $572,000 | +450.0% | 254,016 | +701.1% | 0.00% | – |
| Q3 2016 | $104,000 | +28.4% | 31,708 | +13.2% | 0.00% | – |
| Q2 2016 | $81,000 | -61.8% | 28,009 | -8.7% | 0.00% | – |
| Q1 2016 | $212,000 | -35.8% | 30,663 | -18.9% | 0.00% | – |
| Q4 2015 | $330,000 | +46.0% | 37,820 | +9.3% | 0.00% | – |
| Q3 2015 | $226,000 | -29.6% | 34,606 | +18.5% | 0.00% | – |
| Q2 2015 | $321,000 | -29.6% | 29,194 | +8.5% | 0.00% | – |
| Q1 2015 | $456,000 | +338.5% | 26,906 | +313.5% | 0.00% | – |
| Q4 2014 | $104,000 | +44.4% | 6,507 | -37.7% | 0.00% | – |
| Q3 2014 | $72,000 | -20.9% | 10,441 | -7.7% | 0.00% | – |
| Q2 2014 | $91,000 | +810.0% | 11,309 | +943.3% | 0.00% | – |
| Q1 2014 | $10,000 | -84.1% | 1,084 | -87.3% | 0.00% | – |
| Q4 2013 | $63,000 | -84.0% | 8,507 | -78.8% | 0.00% | – |
| Q2 2013 | $393,000 | – | 40,075 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|